• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奎克凝血酶原时间试验对口服抗凝剂的反应。凝血活酶来源和氯化钙浓度的影响。

The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.

作者信息

van den Besselaar A M

机构信息

Department of Haematology, Leiden University Hospital, The Netherlands.

出版信息

Arch Pathol Lab Med. 1994 Feb;118(2):145-9.

PMID:8311653
Abstract

The response of the prothrombin time to oral anticoagulant treatment depends on the thromboplastin reagent and method of testing. A prothrombin time assay system may be characterized by its international sensitivity index (ISI) with which a coumarin-treated patient's international normalized ratio can be calculated. Both the anticoagulant (sodium oxalate or sodium citrate) and calcium chloride concentrations influenced the ISI. An ISI of 2.0 was obtained for Quick's prothrombin time assay using rabbit brain thromboplastin. Replacing rabbit brain by human brain thromboplastin (Aggeler's method) resulted in an ISI of 1.3. The results described herein are mainly of historical interest and may assist in the interpretation of anticoagulation intensity in early American recommendations.

摘要

凝血酶原时间对口服抗凝治疗的反应取决于凝血活酶试剂和检测方法。凝血酶原时间测定系统可用国际敏感指数(ISI)来表征,通过该指数可计算香豆素治疗患者的国际标准化比值。抗凝剂(草酸钠或柠檬酸钠)和氯化钙浓度均会影响国际敏感指数。使用兔脑凝血活酶进行Quick凝血酶原时间测定时,国际敏感指数为2.0。用人脑凝血活酶替代兔脑凝血活酶(Aggeler法),国际敏感指数为1.3。本文所述结果主要具有历史意义,可能有助于解读早期美国建议中的抗凝强度。

相似文献

1
The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.奎克凝血酶原时间试验对口服抗凝剂的反应。凝血活酶来源和氯化钙浓度的影响。
Arch Pathol Lab Med. 1994 Feb;118(2):145-9.
2
[Obtaining a reference pattern of rabbit brain thromboplastin].[获取兔脑凝血活酶的参考模式]
Rev Invest Clin. 1989 Jul-Sep;41(3):247-52.
3
Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.在接受口服抗凝剂治疗的患者中使用乙二胺四乙酸(EDTA)样本进行凝血酶原时间测定。
Haematologica. 2001 Aug;86(8):851-5.
4
[Prothrombin time and its standardization].[凝血酶原时间及其标准化]
Rinsho Byori. 2002 Aug;50(8):779-85.
5
Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.美拉加群对凝血酶原时间测定的影响取决于凝血活酶的敏感性和血浆样本的最终稀释度。
Thromb Haemost. 2001 Aug;86(2):611-5.
6
[Initial experiences with a recombinant human tissue thromboplastin in oral anticoagulation].[重组人组织凝血活酶用于口服抗凝治疗的初步经验]
Schweiz Med Wochenschr. 1993 Jan 23;123(3):74-6.
7
Effect of concentration of trisodium citrate anticoagulant on calculation of the International Normalised Ratio and the International Sensitivity Index of thromboplastin.枸橼酸钠抗凝剂浓度对国际标准化比值及凝血活酶国际敏感指数计算的影响
Thromb Haemost. 1994 Jul;72(1):84-8.
8
Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.通过凝血酶原时间探讨稳定口服抗凝治疗患者中凝血活酶试剂对凝血因子水平的差异敏感性:对国际标准化比值系统的影响
Haematologica. 2002 Dec;87(12):1265-73.
9
[Comparison of a sensitive rabbit brain thromboplastin and a human placenta thromboplastin for thromboplastin time determination].[用于凝血酶原时间测定的敏感兔脑凝血活酶与人胎盘凝血活酶的比较]
Schweiz Med Wochenschr. 1989 Feb 11;119(6):178-83.
10
Effect of magnesium contamination in evacuated blood collection tubes on the prothrombin time test and ISI calibration using recombinant human thromboplastin and different types of coagulometer.真空采血管中镁污染对使用重组人凝血活酶和不同类型凝血仪进行凝血酶原时间测试及国际敏感度指数校准的影响。
Thromb Res. 2005;115(3):239-44. doi: 10.1016/j.thromres.2004.08.019.

引用本文的文献

1
Clinical utilization of the international normalized ratio (INR).国际标准化比值(INR)的临床应用。
J Clin Lab Anal. 2000;14(3):101-14. doi: 10.1002/(sici)1098-2825(2000)14:3<101::aid-jcla4>3.0.co;2-a.